⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5272159 | 0.89 | TRPV1 (0.51) | — | |
| SCHEMBL5325440 | 0.87 | TRPV1 (0.52) | — | |
| SCHEMBL14384563 | 0.85 | HPGD (0.56) | — | |
| SCHEMBL5278029 | 0.84 | TRPV1 (0.52) | — | |
| SCHEMBL5276354 | 0.83 | HPGD (0.56) | — | |
| SCHEMBL3778847 | 0.82 | — | — | |
| SCHEMBL14384570 | 0.82 | TRPV1 (0.54) | — | |
| SCHEMBL5801220 | 0.81 | KMT2A (0.56) | — | |
| SCHEMBL12269584 | 0.81 | ALDH1A1 (0.58) | — | |
| SCHEMBL5325255 | 0.80 | TRPV1 (0.62) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1857440-A1 | Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same | Amorepacific Corporation (KR) | 2007-11-21 | — | — | EP | disclosed |
| EP-1857440-A1 | Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same | Amorepacific Corporation (KR) | 2007-11-21 | — | — | EP | disclosed |